Phytochemicals and age-related eye diseases

Nutrition Reviews

Volumn 66, Issue 8, 2008, Pages 465-472

  Rhone, Michael ^a   Basu, Arpita ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Age related eye diseases; Anthocyanins; Lutein; Oxidative stress; Zeaxanthin

Indexed keywords

ALPHA TOCOPHEROL; ANTHOCYANIN; ASCORBIC ACID; ASTAXANTHIN; BETA CAROTENE; COPPER; EPIGALLOCATECHIN GALLATE; GINKGO BILOBA EXTRACT; GLUTATHIONE; GREEN TEA EXTRACT; PLANT MEDICINAL PRODUCT; RESVERATROL; XANTHOPHYLL; ZEAXANTHIN; ZINC;

CATARACT; CLINICAL FEATURE; CLINICAL TRIAL; DIETARY INTAKE; DRUG ACCUMULATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG MECHANISM; GLAUCOMA; HUMAN; NONHUMAN; OBESITY; OXIDATIVE STRESS; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SINGLE DRUG DOSE; SMOKING; TREATMENT OUTCOME;

AGED; AGING; ANTIOXIDANTS; CATARACT; EYE DISEASES; FLAVONOIDS; GLAUCOMA; HUMANS; LUTEIN; MACULAR DEGENERATION; MIDDLE AGED; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; OXIDATIVE STRESS; PHYTOTHERAPY; PLANTS, EDIBLE; XANTHOPHYLLS;

GINKGO BILOBA;

EID: 48349141655     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2008.00078.x     Document Type: Review

References (65)

1. Congdon N, O'Colmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004 122 : 477 485.
2. Richer S. A primer on ocular nutrition. Rev Optom. 2004 (Suppl 141 : 12 13.
3. Stokkermans TJW. Can patients eat their way to improved vision? Rev Optom. 2005 (Suppl 8 10.
4. Ohira A, Ueda T, Ohishi K, Hiramitsu T, Akeo K, Obara Y. Oxidative stress in ocular disease Nippon Ganka Gakkai Zasshi. 2008 112 : 22 29.
5. Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000 45 : 115 134.
6. Izzotti A, Bagnis A, Sacca SC. The role of oxidative stress in glaucoma. Mutat Res. 2006 612 : 105 114.
7. Ko ML, Peng PH, Ma MC, Ritch R, Chen CF. Dynamic changes in reactive oxygen species and antioxidant levels in retinas in experimental glaucoma. Free Radic Biol Med. 2005 39 : 365 373.
8. Head KA. Natural therapies for ocular disorders, part two: cataracts and glaucoma. Altern Med Rev. 2001 6 : 141 166.
9. Beit-Yannai E, Trembovler V, Solomon AS. Decrease in reducing power of aqueous humor originating from glaucomatous rabbits. Eye 2007 21 : 658 664.
10. Fernandez MM, Afshari NA. Nutrition and the prevention of cataracts. Curr Opin Ophthalmol. 2008 19 : 66 70.
11. Nelson JL, Bernstein PS, Schmidt MC, Von Tress MS, Askew EW. Dietary modification and moderate antioxidant supplementation differentially affect serum carotenoids, antioxidant levels and markers of oxidative stress in older humans. J Nutr. 2003 133 : 3117 3123.
12. Santosa S, Jones PJH. Oxidative stress in ocular disease: does lutein play a protective role? CMAJ. 2005 173 : 861 862.
13. West AL, Oren GA, Moroi SE. Evidence for the use of nutritional supplements and herbal medicines in common eye diseases. Am J Ophthalmol. 2006 141 : 157 166.
14. Gao X, Talalay P. Induction of phase 2 genes by sulforaphane protects retinal pigment epithelial cells against photooxidative damage. Proc Natl Acad Sci USA. 2004 101 : 10446 10451.
15. King RE, Kent KD, Bomser JA. Resveratrol reduces oxidation and proliferation of human retinal pigment epithelial cells via extracellular signal-regulated kinase inhibition. Chem Biol Interact. 2005 151 : 143 149
16. Wattanapenpaiboon N, Wahlqvist ML. Phytonutrient deficiency: the place of palm fruit. Asia Pac J Clin Nutr. 2003 12 : 363 368.
17. Zafra-Stone S, Yasmin T, Bagchi M, Chatterjee A, Vinson JA, Bagchi D. Berry anthocyanins as novel antioxidants in human health and disease prevention. Mol Nutr Food Res. 2007 51 : 675 683.
18. Kalt W, Blumberg JB, McDonald JE, et al. Identification of anthocyanins in the liver, eye, and brain of blueberry-fed pigs. J Agric Food Chem 2008 56 : 705 712.
19. Mozaffarieh M, Flammer J. Is there more to glaucoma treatment than lowering IOP? Surv Ophthalmol. 2007 52 (Suppl 2 S174 S179.
20. Taylor A, Jacques PF, Chylack LT, Hankinson SE, Khu PM, Rogers G, Friend J, Tung W, Wolfe JK, Padhye N, Willett WC. Long-term intake of vitamins and carotenoids and odds of early age-related cortical and posterior subcapsular lens opacities. Am J Clin Nutr. 2002 75 : 540 549.
21. Kuzniarz M, Mitchell P, Cumming RG, Flood VM. Use of vitamin supplements and cataract: The Blue Mountains Eye Study. Am J Ophthalmol. 2001 132 : 19 26.
22. Chasan-Taber L, Willett WC, Seddon JM, Stampfer MJ, Rosner B, Colditz GA, Speizer FE, Hankinson SE. A prospective study of carotenoid and vitamin A intakes and risk of cataract extraction in US women. Am J Clin Nutr. 1999 70 : 509 516
23. Lyle BJ, Mares-Periman JA, Klein BK, Klein R, Greger JL. Antioxidant intake and risk of incident age-related nuclear cataracts in theBeaver Dam Eye Study. Am J Epidemiol. 1999 149 : 801 809.
24. Shovlin JP. Nutrition and the eye. Rev Optom 2007 144 : 1 1.
25. Chong EW, Wong TY, Kreis AJ, Simpson JA, Guymer RH. Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis. BMJ. 2007 335 : 755.
26. Seddon JM. Multivitamin-multimineral supplements and eye disease: age-related macular degeneration and cataract. Am J Clin Nutr. 2007 85 (Suppl S304 S307.
27. Chiu CJ, Taylor A. Nutritional antioxidants and age-related cataract and maculopathy. Exp Eye Res. 2007 84 : 229 245.
28. Mares JA. High-dose antioxidant supplementation and cataract risk. Nutr Rev. 2004 62 : 28 32.
29. Kang JH, Pasquale LR, Willett W, Rosner B, Egan KM, Faberowski N, Hankinson SE. Antioxidant intake and primary open-angle glaucoma: a prospective study. Am J Epidemiol. 2003 158 : 337 346.
30. Sperduto RD, Hu TS, Milton RC, et al. The Linxian cataract studies. Two nutrition intervention trials. Arch Ophthalmol. 1993 111 : 1246 1253
31. Chylack LT Jr., Brown NP, Bron A, Hurst M, Köpcke W, Thien U, Schalch W. The Roche European American Cataract Trial (REACT): a randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract. Ophthalmic Epidemiol. 2002 9 : 49 80.
32. Meyer CH, Sekundo W. Nutritional supplementation to prevent cataract formation. Dev Ophthalmol. 2005 38 : 103 119.
33. Noertjojo K, Maberley D, Bassett K, Courtright P. Awareness of eye diseases and risk factors: identifying needs for health education and promotion in Canada. Can J Ophthalmol 2006 41 : 617 623.
34. Bonovas S, Filioussi K, Tsantes A, Peponis V. Epidemiological association between cigarette smoking and primary open-angle glaucoma: a meta-analysis. Public Health 2004 118 : 256 261.
35. Cheung N, Wong TY. Obesity and eye diseases. Surv Ophthalmol. 2007 52 : 180 195.
36. Suñer IJ, Espinosa-Heidmann DG, Marin-Castano ME, Hernandez EP, Pereira-Simon S, Cousins SW. Nicotine increases size and severity of experimental choroidal neovascularization. Invest Ophthalmol Vis Sci. 2004 45 : 311 317.
37. Hammond BR Jr., Wooten BR, Snodderly DM. Cigarette smoking and retinal carotenoids: implications for age-related macular degeneration Vision Res. 1996 36 : 3003 3009.
38. Espinosa-Heidmann DG, Suner IJ, Catanuto P, Hernandez EP, Marin-Castano ME, Cousins SW. Cigarette smoke-related oxidants and the development of sub-RPE deposits in an experimental animal model of dry AMD Invest Ophthalmol Vis Sci. 2006 47 : 729 737.
39. Christen WG, Liu S, Glynn RJ, Gaziano JM, Buring JE. Dietary carotenoids, vitamins C and E, and risk of cataract in women: a prospective study. Arch Ophthalmol. 2008 126 : 102 109.
40. SanGiovanni JP, Chew EY, Clemons TE, et al. The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22. Arch Ophthalmol. 2007 125 : 1225 1232.
41. Flood V, Smith W, Wang JJ, Manzi F, Webb K, Mitchell P. Dietary antioxidant intake and incidence of early age-related maculopathy: the Blue Mountains Eye Study. Ophthalmology 2002 109 : 2272 2278.
42. Cho E, Seddon JM, Rosner B, Willett WC, Hankinson SE. Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy. Arch Ophthalmol. 2004 122 : 883 892.
43. Moeller SM, Parekh N, Tinker L, et al. Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-related Eye Disease Study (CAREDS): ancillary study of the Women's Health Initiative. Arch Ophthalmol. 2006 124 : 1151 1162.
44. Parisi V, Tedeschi M, Gallinaro G, Varano M, Saviano S, Piermarocchi S. Carotenoids and antioxidants in age-related maculopathy Italian study: multifocal electroretinogram modifications after 1 year. Ophthalmology 2008 115 : 324 333 e322.
45. Schalch W, Cohn W, Barker FM, et al. Xanthophyll accumulation in the human retina during supplementation with lutein or zeaxanthin - the LUXEA (LUtein Xanthophyll Eye Accumulation) study. Arch Biochem Biophys. 2007 458 : 128 135.
46. Bone RA, Landrum JT, Guerra LH, Ruiz CA : Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans. J Nutr. 2003 133 : 992 998.
47. Olmedilla B, Granado F, Blanco I, Vaquero M, Cajigal C. Lutein in patients with cataracts and age related macular degeneration: a long term supplementation study. J Sci Food Agric. 2001 81 : 904 909.
48. Thiagarajan G, Chandani S, Harinarayana Rao S, Samuni AM, Chandrasekaran K, Balasubramanian D. Molecular and cellular assessment of Ginkgo biloba extract as a possible ophthalmic drug. Exp Eye Res. 2002 75 : 421 430.
49. Nishida S, Satoh H. Comparative vasodilating actions among terpenoids and flavonoids contained in Ginkgo biloba extract. Clin Chim Acta. 2004 339 : 129 133.
50. Wimpissinger B, Berisha F, Garhoefer G, Polak K, Schmetterer L. Influence of Ginkgo biloba on ocular blood flow. Acta Ophthalmol Scand. 2007 85 : 445 449.
51. Chung HS, Harris A, Kristinsson JK, Ciulla TA, Kagemann C, Ritch R. Ginkgo biloba extract increases ocular blood flow velocity. J Ocul Pharmacol Ther. 1999 15 : 233 240.
52. Quaranta L, Bettelli S, Uva MG, Semeraro F, Turano R, Gandolfo E. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma. Ophthalmology. 2003 110 : 359 364.
53. Rahman I, Biswas SK, Kirkham PA. Regulation of inflammation and redox signaling by dietary polyphenols. Biochem Pharmacol. 2006 72 : 1439 1452.
54. Mazza G, Kay CD, Cottrell T, Holub BJ. Absorption of anthocyanins from blueberries and serum antioxidant status in human subjects J Agric Food Chem. 2002 50 : 7731 7737.
55. Matsumoto H, Nakamura Y, Iida H, Ito K, Ohguro H. Comparative assessment of distribution of blackcurrant anthocyanins in rabbit and rat ocular tissues. Exp Eye Res. 2006 83 : 348 356.
56. Shih PH, Yeh CT, Yen GC. Anthocyanins induce the activation of phase II enzymes through the antioxidant response element pathway against oxidative stress-induced apoptosis. J Agric Food Chem. 2007 55 : 9427 9435.
57. Jang YP, Zhou J, Nakanishi K, Sparrow JR. Anthocyanins protect against A2E photooxidation and membrane permeabilization in retinal pigment epithelial cells. Photochem Photobiol. 2005 81 : 529 536.
58. Milbury PE, Graf B, Curran-Celentano JM, Blumberg JB. Bilberry (Vaccinium myrtillus) anthocyanins modulate heme oxygenase-1 and glutathione S-transferase-pi expression in ARPE-19 cells. Invest Ophthalmol Vis Sci. 2007 48 : 2343 2349.
59. Durukan AH, Evereklioglu C, Hurmeric V, Kerimoglu H, Erdurman C, Bayraktar MZ, Mumcuoglu T. Ingestion of IH636 grape seed proanthocyanidin extract to prevent selenite-induced oxidative stress in experimental cataract. J Cataract Refract Surg. 2006 32 : 1041 1045.
60. Karlsen A, Retterstol L, Laake P, et al. Anthocyanins inhibit nuclear factor-kappaB activation in monocytes and reduce plasma concentrations of pro-inflammatory mediators in healthy adults. J Nutr. 2007 137 : 1951 1954.
61. Miura D, Miura Y, Yagasaki K. Resveratrol inhibits hepatoma cell invasion by suppressing gene expression of hepatocyte growth factor via its reactive oxygen species-scavenging property. Clin Exp Metastasis. 2004 21 : 445 451.
62. Sun W, Wang W, Kim J, Keng P, Yang S, Zhang H, Liu C, Okunieff P, Zhang L. Anti-cancer effect of resveratrol is associated with induction of apoptosis via a mitochondrial pathway alignment. Adv Exp Med Biol. 2008 614 : 179 186.
63. Doganay S, Borazan M, Iraz M, Cigremis Y. The effect of resveratrol in experimental cataract model formed by sodium selenite. Curr Eye Res. 2006 31 : 147 153.
64. Zhang B, Safa R, Rusciano D, Osborne NN. Epigallocatechin gallate, an active ingredient from green tea, attenuates damaging influences to the retina caused by ischemia/reperfusion. Brain Res. 2007 1159 : 40 53.
65. Gupta SK, Halder N, Srivastava S, Trivedi D, Joshi S, Varma SD. Green tea (Camellia sinensis) protects against selenite-induced oxidative stress in experimental cataractogenesis. Ophthalmic Res. 2002 34 : 258 263.